BIOSIM Act
Summary
Bolstering Innovative Options to Save Immediately on Medicines Act or the BIOSIM Act This bill increases Medicare payments for biosimilars for five years. The bill applies to biosimilars for which the average sales price or wholesale acquisition cost is less than that of the reference biological product, as specified.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2021
Committee Review
Floor Vote
President
Introduced Apr 22, 2021
Last action Apr 23, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
5
Key actions
0
Committee
4
Apr 23, 2021
Committee
Referred to the Subcommittee on Health.
lower
Apr 22, 2021
Committee
Referred to the Subcommittee on Social Security.
lower
Apr 22, 2021
Committee
Referred to the Subcommittee on Health.
lower
Apr 22, 2021
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Apr 22, 2021
Introduced
Introduced in House
lower
1 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 2815
Scope: US
Hi! I can help you understand HR 2815. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline